论文部分内容阅读
本文用放免法（RIA）检测了40例肝癌患者血CA125，并对结果进行分析和探讨。对象和方法1对象40例肝癌患者均来自专科门诊和住院病人，都经临床明确诊断为原发性肝癌，其中合并肝硬化腹水者10例，有肝内外转移者16例，余14例患者无明显并发症。男性39例，女性1例，年龄38～78岁
In this article, CA125 was detected in 40 patients with hepatocellular carcinoma by radioimmunoassay (RIA), and the results were analyzed and discussed. Subjects and Methods 1 Subjects 40 patients with hepatocellular carcinoma were from specialist outpatients and inpatients. They were all diagnosed as primary liver cancer. Among them, 10 were associated with cirrhosis with ascites, 16 with intrahepatic metastases, and 14 patients without Obvious complications. 39 males and 1 female, aged 38-78 years